DIRS.INFO The most relevant business & tech news

☆ Stocks making the biggest moves midday: Moderna, Pepsi, Lyft and more
▼ + stars: | 2022-10-12 | by ( Michelle Fox | ) www.cnbc.com time to read: +3 min

Pepsi products are displayed for sale in a Target store on March 8, 2022 in Los Angeles, California. Check out the companies making the biggest moves midday Wednesday:Moderna — Shares of Moderna surged 10% after the drug maker announced it will partner with Merck to jointly develop and sell a cancer vaccine. It reported preliminary month-end assets under management of $1.23 trillion as of Sept. 30. Pepsi also raised its guidance for the year as it was able to successfully raise prices on its products. Lyft — Lyft shares gained 5.8% following an upgrade from Gordon Haskett to buy from hold.

☆ U.S. authorizes updated COVID booster shots for children as young as 5
▼ + stars: | 2022-10-12 | by ( ) www.reuters.com time to read: +2 min

Oct 12 (Reuters) - U.S. health regulators authorized the use of Omicron-tailored COVID-19 booster shots from Moderna Inc (MRNA.O) and Pfizer Inc (PFE.N) in children as young as 5, a move that will expand the government's fall vaccination campaign. The U.S. Food and Drug Administration on Wednesday green-lighted Moderna's bivalent vaccine for those aged six and above, while Pfizer's updated shot was authorized in children aged five and above. The U.S. Centers for Disease Control and Prevention also backed the FDA's authorization, clearing the way for the shots to be administered in children. Overall, COVID-19 vaccination rates in the United States have stayed low among kids, with nearly 40% of children aged 5-11 vaccinated with one dose of a vaccine so far. Around 11.5 million people received the updated shots over the first five weeks of the rollout last month, which represents just 5.4% of the people aged 12 or older who are eligible to receive them.

☆ FDA authorizes Covid omicron booster shots for kids as young as 5 years old
▼ + stars: | 2022-10-12 | by ( Spencer Kimball | ) www.cnbc.com time to read: +3 min

The Food and Drug Administration on Wednesday authorized Covid booster shots that target the omicron variant for preschoolers through elementary school students. Pfizer's new omicron boosters are now authorized for children ages 5 to 11 and Moderna's shots for kids ages 6 through 17. The new boosters target omicron BA.5 as well as the original strain of Covid that first emerged in Wuhan, China, in 2019. The first generation of Covid shots were developed in 2020 to target the original strain of Covid. More than 11 million Americans ages 12 and older have received the new booster shots so far, according to CDC data.

☆ Jim Cramer goes over the best and worst Q3 performers in the S&P 500
▼ + stars: | 2022-10-11 | by ( Krystal Hur | ) www.cnbc.com time to read: +2 min

In this article CEGENPHETSYNFLXBIIBVFCCTLTLUMNFDX Follow your favorite stocks CREATE FREE ACCOUNTwatch nowCNBC's Jim Cramer on Tuesday gave his take on the winning and losing stocks in the S&P 500 during the third quarter. WinnersZoom In Icon Arrows pointing outwardsConstellation Energy Cramer said that the company is "perfectly crafted" for the ESG movement. Netflix The company's stock should be able to continue gaining if Netflix doesn't botch the launch of its ad-supported tier, he predicted. Biogen Cramer said he has faith in the company's Alzheimer's drug, though he believes Eli Lilly's will be better. VF Corp Cramer said he has no faith in the apparel stock's ability to rally in the current inflationary environment.

☆ U.S. is tracking several omicron subvariants, but new boosters should offer protection, White House says
▼ + stars: | 2022-10-11 | by ( Spencer Kimball | ) www.cnbc.com time to read: +3 min

White House COVID-19 Response Coordinator Dr. Ashish Jha speaks to reporters during a press briefing with White House Press Secretary Karine Jean-Pierre at the White House on July 25, 2022 in Washington, DC. The U.S. is tracking several coronavirus omicron subvariants that more easily evade immunity, but the new booster shots should protect against them, a top health official said on Tuesday. Health officials are closely watching the subvariants because they render many treatments ineffective, said Dr. Ashish Jha, head of the White House Covid task force. But the new booster shots available in the U.S. should provide a much higher degree of protection against the variants because they all descend from omicron BA.2 or omicron BA.5, Jha told reporters at the White House. The Biden administration had to shift money around to find funding to stockpile the new booster shots.

☆ Pfizer or Moderna: Which new omicron-specific Covid booster should you get?
▼ + stars: | 2022-09-27 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

Americans have two options for a new omicron-specific Covid booster shot: Pfizer or Moderna. Pfizer's booster is cleared for anyone 12 and older, while Moderna's booster is for people 18 and older. "People ages 18 years and older may get a different product for a booster than they got for their primary series, as long as it is [Pfizer or Moderna,]" the CDC's website reads. "It's OK to mix and match Moderna and Pfizer," Dr. Ralph Gonzales, associate dean for clinical innovation at UC San Francisco, said at a campus town hall earlier this month. I definitely felt a stronger response with the Moderna — having had Pfizer before — but either combinations are fine."

☆ U.S. FDA clears additional lots of Moderna's Covid booster amid shortage
▼ + stars: | 2022-09-26 | by ( ) www.reuters.com time to read: +1 min

A healthcare worker holds a vial of the Moderna COVID-19 Vaccine at a pop-up vaccination site operated by SOMOS Community Care during the coronavirus disease (COVID-19) pandemic in Manhattan in New York City, New York, U.S., January 29, 2021. REUTERS/Mike Segar/File PhotoSept 26 (Reuters) - The U.S. Food and Drug Administration said on Monday it has authorized an additional five batches of Moderna Inc's (MRNA.O) updated Covid booster shots made at a Catalent facility in Indiana, after it deemed them safe for use. Last week, the health regulator had allowed use of ten batches of Moderna's updated booster shots made at the Bloomington, Indiana facility, owned by a unit of Catalent Inc (CTLT.N), which is currently not a part of the company's emergency use authorization. The FDA had earlier said Moderna had requested authorization for additional batches in light of the current supply issues. The U.S. government, which has sent out over 25 million of the COVID-19 booster shots targeting BA.4 and BA.5 subvariants of Omicron, has ordered more than 170 million updated shots for this fall, in preparation for a broad revaccination campaign.

☆ Pfizer, Moderna seek authorization for updated Covid-19 boosters for younger children
▼ + stars: | 2022-09-26 | by ( Naomi Thomas | ) edition.cnn.com time to read: +1 min

(CNN) Younger children could soon be eligible to receive an updated Covid-19 booster shot. Pfizer and BioNTech on Monday said they completed their submission to the US Food and Drug Administration for emergency use authorization of their updated Covid-19 booster for children ages 5 through 11. Moderna on Friday said it had requested FDA authorization for its updated booster for adolescents ages 12 to 17 and for children ages 6 to 11. Like the boosters that became available for older people earlier this month, these bivalent boosters target the original coronavirus strain as well as the Omicron BA.4/BA.5 subvariants. Pfizer's updated booster is currently authorized for use in people 12 and older and Moderna's is authorized for adults age 18 and older.

☆ Pfizer asks FDA to authorize omicron Covid booster shots for kids ages 5 to 11
▼ + stars: | 2022-09-26 | by ( Spencer Kimball | ) www.cnbc.com time to read: +2 min

Pfizer on Monday asked the Food and Drug Administration to authorize its new Covid booster shots that target the omicron BA.5 subvariant for children ages 5 to 11. The company, in a statement, said its request is based on human data from a similar vaccine that targets the omicron BA.1 subvariant and data from animal studies on the BA.5 shots. Pfizer's main competitor on Covid shots, Moderna, asked the FDA to authorize its omicron shots for kids ages 6 through 17 on Friday. Officials at the FDA and CDC expect the omicron BA.5 shots will provide significantly better protection against infection and disease this fall and winter. The new boosters target the dominant omicron BA.5 subvariant as well as the original strain of Covid that first emerged in Wuhan, China in 2019.

☆ Canada to remove all Covid travel restrictions from Oct. 1
▼ + stars: | 2022-09-26 | by ( ) www.cnbc.com time to read: +2 min

Cars line up at Canadian side of the border between Canada and the United States, near Seattle, Washington and Vancouver, British Columbia on August 9, 2021. Canada will drop all Covid-19 restrictions for travelers from Oct. 1, including vaccination and masking requirements for flights and trains, the government said on Monday. The move is likely to boost the Canadian travel industry, already booming after months of lull during the pandemic. More than 90% of Canadians over 12 have taken the primary series of a Covid vaccine. Cruise ship passengers and crew would also no longer be subject to vaccine requirements or Covid testing.

☆ Pfizer CEO tests positive for COVID for a second time
▼ + stars: | 2022-09-24 | by ( ) www.reuters.com time to read: +2 min

Register now for FREE unlimited access to Reuters.com RegisterAlbert Bourla, CEO of Pfizer attends a discussion at the World Economic Forum (WEF) in Davos, Switzerland May 25, 2022. REUTERS/Arnd WiegmannSept 24 (Reuters) - Pfizer Inc (PFE.N) Chief Executive Officer Albert Bourla said on Saturday he had tested positive for COVID-19. Bourla has received four doses of the COVID vaccine developed by Pfizer and its German partner BioNTech (22UAy.DE). A federal health agency said this week that over 25 million doses of the so-called bivalent shots had been sent out. read moreRegister now for FREE unlimited access to Reuters.com RegisterReporting by Mrinmay Dey in Bengaluru; Editing by Daniel WallisOur Standards: The Thomson Reuters Trust Principles.

☆ Less than 2% of U.S. adults have gotten updated Covid booster shots
▼ + stars: | 2022-09-23 | by ( Aria Bendix | Aria Bendix Is The Breaking Health Reporter For Nbc News Digital. | ) www.nbcnews.com time to read: +5 min

At least 4.4 million people have received an updated Covid booster since the start of the month, according to data released Thursday by the Centers for Disease Control and Prevention. The CDC signed off on updated versions of Pfizer’s and Moderna’s booster shots on Sept. 1, and pharmacies and other vaccination sites began administering the new shots around Labor Day weekend. As of Tuesday, the U.S. had shipped more than 25 million bivalent booster doses to tens of thousands of sites. Some pharmacies reported shortages of Moderna's updated booster earlier this week. Biden administration officials have pointed to the updated boosters, however, as a critical step to pushing the U.S. out of the pandemic.

☆ Moderna asks FDA to authorize omicron Covid boosters for children as young as 6 years old
▼ + stars: | 2022-09-23 | by ( Spencer Kimball | ) www.cnbc.com time to read: +2 min

Moderna has asked the Food and Drug Administration to authorize its omicron booster shots for children, the company announced on Friday. The Centers for Disease Control and Prevention, in a document published Tuesday, said it expects children to become eligible for the omicron boosters by mid-October pending authorization by the FDA. Pfizer told the CDC advisory committee earlier this month that it expects to ask the FDA to authorize omicron boosters for children ages 5 to 11 in early October. U.S. health regulators cleared Moderna's omicron boosters for adults earlier this month. There is also concern that the original shots' effectiveness at preventing hospitalization and severe illness is starting to decline.

☆ Moderna seeks FDA nod for Omicron-targeted COVID shot for adolescents, younger kids
▼ + stars: | 2022-09-23 | by ( ) www.reuters.com time to read: +1 min

Register now for FREE unlimited access to Reuters.com RegisterA vial labelled "Moderna COVID-19 Vaccine" is seen in this illustration taken January 16, 2022. The company is seeking emergency use authorization of its updated vaccine in two age groups - adolescents aged 12 to 17 years and children aged six to 11. Moderna's mRNA-1273.222, a bivalent booster shot, contains the dominant BA.4/BA.5 variants along with the original coronavirus strain. read moreThe U.S. government has ordered more than 170 million updated vaccine booster shots for this fall, and said on Tuesday it had sent out over 25 million doses to be distributed. Register now for FREE unlimited access to Reuters.com RegisterReporting by Mrinalika Roy in Bengaluru; Editing by Shinjini GanguliOur Standards: The Thomson Reuters Trust Principles.

☆ Omicron-specific Covid boosters for children ages 5 to 11 are 'only a matter of weeks away,' says FDA vaccine chief
▼ + stars: | 2022-09-22 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +1 min

New omicron-specific Covid boosters for children ages 5 to 11 are "only a matter of weeks away," according to the U.S. Food and Drug Administration's vaccine chief. Marks added that an authorization for the youngest age group — kids under 5 — is still "a few months away." The CDC expects Pfizer's redesigned booster to be for children ages 5 to 11, and Moderna's to be for children ages 6 to 17. Currently, children ages 5 to 11 are only eligible to receive Covid vaccines for their primary series, and a single monovalent booster dose from Pfizer. If the new bivalent boosters receive approval from the FDA and CDC, the monovalent boosters may no longer be authorized for the age group, according to the CDC's planning guide.

☆ See the presentations that cutting-edge biotech companies have used to raise millions from top investors
▼ + stars: | 2022-09-22 | by ( Leah Rosenbaum | ) www.businessinsider.com time to read: +6 min

Funding for biotech companies soared in 2021 to nearly $47 billion — a record for the industry. Insider rounded up all the biotech pitch decks we've published, from those seeking early-stage funding to presentations for late-stage rounds, that have helped companies raise money from investors. Here's the 24-slide pitch deck the company used to raise $175 million from investors like Leaps by Bayer. Here is the 24-slide pitch deck the company used to raise $120 million and prepare for regulatory approval in Japan. In late-stage funding rounds, the investors might also be different or used to backing bigger companies.

☆ U.S. CDC expects Omicron COVID boosters for kids by mid-October
▼ + stars: | 2022-09-21 | by ( ) www.reuters.com time to read: +1 min

REUTERS/Hannah BeierSept 21 (Reuters) - The U.S. Centers for Disease Control and Prevention expects COVID-19 vaccine boosters targeting circulating variants of the virus to be available for children aged 5-11 years by mid-October. Register now for FREE unlimited access to Reuters.com RegisterThe CDC said it expects Pfizer-BioNTech's (PFE.N), bivalent vaccine to be available for children aged 5-11 years, and Moderna's (MRNA.O) vaccine for those aged 6-17 years, pending FDA authorization. The Pfizer vaccine is already authorized as a booster dose for children over 12 years of age, while Moderna's bivalent vaccine is authorized for adults. The CDC expects pre-orders for the Pfizer shot to begin for the age group next week. The Moderna vaccine will have the same formulation for children and adults and will not require a separate pre-order period, the CDC said.

☆ U.S. delivers over 25 mln COVID boosters; Moderna's shot in limited supply
▼ + stars: | 2022-09-20 | by ( ) www.reuters.com time to read: +2 min

A nurse fills up syringes with the coronavirus disease (COVID-19) vaccines for residents who are over 50 years old and immunocompromised and are eligible to receive their second booster shots in Waterford, Michigan, U.S., April 8, 2022. Both CVS and Walgreens said they are working with the government to acquire more Moderna doses and have not seen any supply issues for the Pfizer/BioNTech booster. Register now for FREE unlimited access to Reuters.com RegisterIn August, the U.S. Food and Drug Administration authorized Pfizer and Moderna's updated booster shots that target the dominant BA.4 and BA.5 Omicron subvariants, as the country prepares for a broad fall revaccination campaign. It said it expects to ship the 70 million doses by the end of the year, as promised in its contract. The U.S. has ordered more than 170 million updated vaccine booster shots for this fall when all individuals aged 12 and over who have already received the initial doses of the vaccine are being encouraged to receive a booster shot.

☆ 1 in 3 workers fear they'll catch Covid by returning to the office—here's how to keep yourself healthy
▼ + stars: | 2022-09-19 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +5 min

A recent Gallup poll found that one in three U.S. workers are "very" or "moderately" concerned about Covid exposure at work. Stay up-to-date on your Covid vaccinesStaying up-to-date on your vaccines is the best way to protect yourself from Covid. That means completing your primary series and receiving the booster shots you're eligible for. You'll need to be at least two months out from your last dose of any Covid shot, the CDC says. Have completed your primary series, but are immunocompromisedHave completed your primary series and are in an area with a substantial or high level spread of Covid.

☆ Time to get your Omicron booster shot. Here's everything you need to know about the 2 vaccines offered, and when to get it.
▼ + stars: | 2022-09-09 | by ( Hilary Brueck | ) www.businessinsider.com time to read: +5 min

New, reformulated COVID-19 booster shots are out from Pfizer and Moderna. These may be the last free COVID-19 vaccines you'll getThis fall booster campaign is likely the last chance you'll get to have free COVID-19 shots from the US government. Epidemiologist Katelyn Jetelina recommends waiting at least two months after a COVID-19 infection, the same as you would after any previous COVID-19 shot. "One COVID-19 shot, once a year, each fall," he said on Tuesday in a statement. Many are hoping that new kinds of COVID-19 vaccines being developed could be better long-term solutions than the shots we have now.

Search resuls for: "Moderna's"

20 mentions found